Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates.
about
Rituximab for thyroid-associated ophthalmopathyRituximab for thyroid-associated ophthalmopathyGraves' ophthalmopathyRituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathyCorrelation of HLA-DQ and TNF-α gene polymorphisms with ocular myasthenia gravis combined with thyroid-associated ophthalmopathyRandomized controlled trial of rituximab in patients with Graves' orbitopathyRituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyClinical efficacy of combined rituximab treatment in a woman with severe Graves' ophthalmopathyRituximab Treatment in a Patient with Active Graves' Orbitopathy and Psoriasis.Feasibility of tomotherapy for Graves' ophthalmopathy: Dosimetry comparison with conventional radiotherapy.Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study.
P2860
Q24202845-80716EF3-D5CB-4A34-9541-350CA6105A55Q24235160-615F8631-D24D-4ACE-9CD9-74920266E32EQ28274196-D2C134FE-68D8-4C49-AB3E-144462198BCAQ33624477-074C7F04-E174-4846-8962-51B30E0F6C49Q33792654-8D2FC507-58BC-44CB-A16A-C656FCC2E980Q35055124-72564F84-01C3-424A-9E35-B7737F4A7F8CQ35064588-883C463A-465D-4918-8D8E-17FF830EA62FQ36811289-2DEE9F1C-8057-47D6-830A-CC4177A5C96FQ37106626-5F172030-28CD-4959-9ED6-B8C1E6C3A04DQ37615281-D34362E1-0C60-444D-87C5-B367256F4886Q37895514-7F3B4BB9-4195-45E8-BC46-D8AC17D2103FQ40095263-49904820-1E00-425B-AC76-A57E7A0DA8C4Q43042591-E6EDF2F0-F56C-43AB-92B3-1A37C274800BQ53059480-5AD4E57C-0CA4-4A83-A6C0-2C910937FB77
P2860
Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Rituximab treatment in a patie ...... bital lymphocytic infiltrates.
@en
Rituximab treatment in a patie ...... bital lymphocytic infiltrates.
@nl
type
label
Rituximab treatment in a patie ...... bital lymphocytic infiltrates.
@en
Rituximab treatment in a patie ...... bital lymphocytic infiltrates.
@nl
prefLabel
Rituximab treatment in a patie ...... bital lymphocytic infiltrates.
@en
Rituximab treatment in a patie ...... bital lymphocytic infiltrates.
@nl
P2093
P1433
P1476
Rituximab treatment in a patie ...... bital lymphocytic infiltrates.
@en
P2093
Claudio Guastella
Danila Covelli
Davide Dazzi
Guia Vannucchi
Irene Campi
Lorenzo Pignataro
Mario Salvi
Paola Bonara
Paolo Beck-Peccoz
Roberto Ratiglia
P304
P356
10.1016/J.CLIM.2008.12.005
P50
P577
2009-02-04T00:00:00Z